The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
HealthyMemory Impairment
Interventions
DRUG

AZD8529

6 capsules by mouth 1 time 12 to 24 prior to assessments

DRUG

Placebo to match AZD8529

6 capsules by mouth 1 time 12 to 24 hours prior to assessments

Trial Locations (1)

Unknown

Research Site, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY